Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Aston Sci. logo — Empowering Patients with Innovative Cancer Immunotherapy

Aston Sci.

Empowering Patients with Innovative Cancer Immunotherapy

Founded 2018 Korea South Korea South 8 employees Series C Total: $27.00B Biotechnology, Pharmaceutical

General Information

Company Name Aston Sci.
Founded Year 2018
Location Korea South Korea South
Founders / Decision Makers
Team member
Employees 8
Industries Biotechnology, Pharmaceutical
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Aston Sci.. To contact Aston Sci., visit astonsci.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aston Sci. compare?

A PDF of Aston Sci. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aston Sci. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aston Sci.

Aston Sci. is a clinical-stage biopharmaceutical company founded in 2018, headquartered in Korea South. The company's slogan, "Empowering Patients with Innovative Cancer Immunotherapy," aligns with its focus on developing innovative medicines in oncology, immunology, and geriatrics. This includes therapeutic cancer vaccines and proteostasis modulators. Aston Sci.'s last investment was a significant KRW27.00B Series C round on 12 January 2021, with participation from prominent investors such as Mirae Asset, Mirae Asset Venture Investment, Timefolio Asset Management, Lakewood Partners, and Gen-tech Investments. The company's mission to prioritize human well-being positions it as a compelling player in the Biotechnology and Pharmaceutical industries. With its innovative approach to cancer immunotherapy, Aston Sci. presents a promising opportunity for venture capital consideration.

Business keywords: clinical-stage biopharmaceutical, oncology, immunology, cancer immunotherapy, therapeutic cancer vaccines, proteostasis modulators, geriatrics, DNA, mRNA, peptide, drug development, pharmaceuticals, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series C KRW27.00B 5
Mirae Asset Mirae Asset Venture Investment Lakewood Partners
Mirae Asset, Mirae Asset Venture Investment +3
12 Jan 2021

Aston Sci. Alternatives & Competitors

View All Alternatives
Aston Sci. vs
Apexigen
Apexigen United States

Creating Transformative Immunotherapies for Patients with Cancer

Post-IPO Equity
11 employees
Biopharma, Biotechnology
Aston Sci. vs
Adlai Nortye
Adlai Nortye

Pioneering the future of oncology with innovative drug development across the globe.

Post-IPO Equity
51-200 employees
Biotechnology, Health Care
Aston Sci. vs
Biond Biologics Ltd
Biond Biologics Ltd Israel

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics for the tre...

Series C
43 employees
Biotechnology, Health Care
View all alternatives

FAQ About Aston Sci.

Empowering Patients with Innovative Cancer Immunotherapy
Aston Sci. was founded in 2018.
Aston Sci. is headquartered in Korea South.
Aston Sci. operates in Biotechnology and Pharmaceutical. Its work centres on clinical-stage biopharmaceutical, oncology, immunology and cancer immunotherapy.
Aston Sci. has approximately 8 employees.
Aston Sci. has completed 1 funding round, raising a total of $27.00B. The latest funding stage is Series C.
Top alternatives and competitors to Aston Sci. include Apexigen, Adlai Nortye, Biond Biologics Ltd, AVEO Oncology, Regor Therapeutics Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aston Sci. and Apexigen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aston Sci., https://bouncewatch.com/company/aston-sci, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout